Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin.
De Jonghe S, Proctor J, Vinken P, Feyen B, Wynant I, Marien D, Geys H, Mamidi RN, Johnson MD.
De Jonghe S, et al. Among authors: geys h.
Chem Biol Interact. 2014 Dec 5;224:1-12. doi: 10.1016/j.cbi.2014.09.018. Epub 2014 Oct 5.
Chem Biol Interact. 2014.
PMID: 25289773